← All trials
NCT04634227
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 24, 2020
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Nov 18, 2020
- Last posted
- Dec 21, 2020
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of IowaLead sponsor
- University of IowaOverall official - principal investigator
- University of IowaSponsor investigator
- University of IowaCollaborator
- St. Baldrick's FoundationCollaborator
- University of IowaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.